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SI Materials and Methods
Mouse RGS16, residues 53–180, was subcloned into a modified
pGEX-2T vector (GE Healthcare) to yield a thrombin-cleavable
GST-fusion of H6RGS1653–180. Plasmid was transformed into
BL21 (DE3) pLysS E. coli and grown to an O.D.600 of 3.0 in
terrific broth (TB) supplemented with 50 g/ml ampicillin at
27°C. Protein expression was induced with 0.5 M IPTG for 6 h
at 27°C. Cells were harvested and resuspended in buffer A (25
mM Tris pH 8.0, 300 mM NaCl, 0.1% -ME, 1 mM PMSF, 5%
glycerol, 5 mM MgCl2). Lysozyme, DNaseI and MgSO4 were
added to final concentrations of 0.1 mg/ml, 10 g/ml and 2.5 mM
respectively and incubated at 4°C for 1 h to initiate lysis. Lysis was
completed by sonication, Triton X-100 added to 0.5% and the
lysate clarified by centrifugation at 36,000  g for 30 min.
Supernatant was applied to 10 ml of glutathione S-Sepharose
(GE Healthcare) equilibrated in buffer B (buffer B  buffer A
without PMSF), washed with 250 ml of buffer B and bound
protein step-eluted with 75 ml of buffer C (buffer C  buffer B
plus 50 mM glutathione pH 8.0). CaCl2 and human -thrombin
were added to 2.5 mM and 2.7 g/ml respectively and incubated
for 18 h at 4°C. Imidazole was added to 20 mM and the digested
fusion protein was applied to 20 ml of Ni2-NTA resin (Qiagen)
equilibrated in buffer D (buffer D  buffer B  20 mM
imidazole). Resin was washed with 400 ml of buffer D and bound
protein was step eluted with 100 ml of buffer E (buffer E 
buffer D plus 0.3 M imidazole). Protein was exchanged into
buffer F (50 mM Tris pH 8.5, 0.1% -ME, 25 mM NaCl and 5
mM MgCl2) and loaded onto a Mono Q 10/10 column (GE
Healthcare) preequilibrated in buffer F. Protein was eluted with
a linear gradient from 25 to 45 mM NaCl 75 ml. Fractions
containing pure H6RGS1653–180 were pooled, exchanged into 5
mM Tris pH 8.0, 0.1% -ME, 5% glycerol, 200 mM NaCl,
concentrated to 17.0 mg/ml, f lash frozen in liquid nitrogen and
stored at 80°C.
For complex formation, the RGS16 construct was reengi-
neered to remove the noncleavableH6-tag. RGS16RGS domain,
residues 53–180, was subcloned into pGEX-2T creating a throm-
bin-cleavable GST tag that, postcleavage, would leave an N-
terminal glycine artifact. Protein was expressed and purified
according to the H6-RGS1653–180 construct except that the
Ni2-NTA columnwas omitted from the procedure and the final,
purified protein was exchanged into 5 mM Tris pH 8.0, 25 mM
NaCl, 5 mM MgCl2, 0.1% -ME, 5% glycerol, concentrated to
49 mg/ml, frozen in liquid nitrogen and stored at 80°C. Mouse
Go in pET15b (Novagen)(gift from John Sondek and Rachelle
Gaudet) was expressed in BL21 (DE3) pLysS cells, grown in 2%
tryptone, 1% yeast extract, 0.5% NaCl, 0.2% glycerol, 50 mM
KH2PO4 pH 7.2 at 30°C to an OD600 of 0.4 and induced for 12 h
with 30 M IPTG and 1 g/ml chloramphenicol. Cells were
harvested, resuspended in buffer G (50 mMTris pH 8.0, 100 mM
NaCl, 0.1% -ME, 10% glycerol, 1 mM PMSF), lysed via
sonication and clarified by centrifugation at 36,000  g for 30
min. Supernatant was loaded onto 20 ml of Ni2-NTA resin
preequilibrated in buffer H (50 mM Tris pH 8.0, 500 mM NaCl,
0.1% -ME, 10 M GDP), washed with 15 column volumes of
buffer H, and eluted with a 0–150 mM imidazole gradient 400
ml in buffer H. Fractions containing H6-Go were pooled,
diluted 3-fold with buffer I (buffer I  buffer H without NaCl),
loaded onto a Q Sepharose Fast Flow column (GE Healthcare),
washed with buffer I supplemented with 30 mMNaCl and eluted
with a 30–500 mM NaCl gradient in buffer I 400 ml. Fractions
containing Go were pooled and the ion exchange protocol
repeated by using a MonoQ 10/10 column. Fractions containing
Go were pooled, exchanged into buffer J (5 mM Tris pH 8.0,
10% glycerol, 0.1% -ME, 100 mM NaCl, 30 mM NaF, 1 mM
AlCl3, 20 mM GDP, 5 M MgCl2) and 5 units of Endo-Lys C
(Roche Molecular Biochemicals) were added and allowed to
proteolyze Go for 48 h at 4°C. An equal volume of buffer I was
added, the sample was filtered over Ni2-NTA resin and the flow
through applied to a MonoQ 10/10 column. The anion exchange
purification protocol was repeated identically as before except
buffers were supplemented with 10 mM NaF, 20 M AlCl3, 100
mM MgCl2 and 20 M GDP. Fractions containing Go were
pooled, concentrated and purified over a Superdex 75 16/60
column (GE Healthcare) in buffer J. Fractions containing Go
were pooled, concentrated to 26 mg/ml, frozen in liquid nitrogen
and stored at 80°C. N-terminal protein sequencing was per-
formed at the Yale Keck microsequencing facility yielding the
sequence NLKEDGISA, indicative of Endo Lys C cleavage
between K21 and N22. To obtain a 1:1 stoichiometric ratio of
Go:RGS16, a 1.5 molar excess of concentrated RGS16 was
added to 150 l of 2.7 mM Go in buffer J, mixed, and allowed
to incubate on ice for 1 h. Sample was injected onto a Superdex
75 16/60 column equilibrated in buffer J and a 1:1 Go:RGS16
complex was separated from excess RGS16. Fractions contain-
ing the complex were pooled, concentrated to 26 mg/ml, frozen
in liquid nitrogen and stored at 80°C.
Crystallization, Data Collection, Structure Determination, and Refine-
ment. H6RGS1653–180 was crystallized by the hanging drop
method, using 1.5 l of 13 mg/ml H6RGS1653–180 and 1.5 l of
mother liquor (34% PEG 400, 150 mM ammonium citrate, 100
mM cacodylate pH 6.5, 500 MKCl6Ir(IV)) equilibrated against
1 ml of mother liquor at 4°C. Crystals were transferred to mother
liquor supplemented with 5% glycerol and frozen in liquid
nitrogen. Data were collected at the NSLS X25 beamline above
the iridium edge at a wavelength of 1.10 Å, using a Brandeis B4
CCD detector and a 100° K cryo stream. Data were processed
and scaled by using HKL2000 (1). Crystals belong to the space
group P212121. Because no iridium sites were found in the crystal,
a molecular replacement solution was obtained by using the CNS
package (2) and the RGS4 RGS domain (PDB 1AGR (3)) as a
search model. Two molecules were found in the asymmetric unit
correlating with a solvent content of 36%. Model building used
the program O (4). Refinement was performed with the CNS
package and monitored with a random 10% of the data that was
removed from the working set and used as a test set for
cross-validation (5). Model refinement used the MLF target
function, rounds of torsion angle molecular dynamics simulated
annealing (6), B factor refinement and rebuilding in O with
A-weighted difference Fourier maps. The final model includes
RGS16 residues 57–180 (chain A), 53–180 (chain B) and 179
water molecules.
GoGDPAlF4RGS16 crystals were grown by the hanging
drop method at 4°C. 1.5 l of GoGDPAlF4RGS16 at 20
mg/ml was mixed with 1.5 l of mother liquor from a 1-ml well
containing 15% PEG 8000 and 200 mM Tris pH 8.5. Crystals
were transferred to a stabilizing solution containing mother
liquor plus 5% ethylene glycol. Ethylene glycol was increased in
5% increments to a final concentration of 30%. Crystals were
then transferred to a solution containing mother liquor supple-
mented with 30% ethylene glycol and 1 mM (Me)3PbOAc for 30
seconds and then frozen in liquid nitrogen. Data were collected
at the NSLS X25 beamline above the lead edge at a wavelength
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of 1.15 Å, using a Brandeis B4 CCD detector and a 100 K cryo
stream. Data were processed and scaled by using HKL2000 (1).
Crystals belong to the space group P3221. No lead sites were
found in the crystal so a molecular replacement solution was
obtained by using the CNS package (2) and the
Gi1GDPAlF4RGS4 structure (PDB 1AGR (3)) as a search
model. Twomolecules were found in the asymmetric unit. Model
building and refinement followed a protocol similar to that
outlined for the RGS16 apo structure. The final model includes
complex 1: Go residues 35–56, 61–194, 198–346 (chain A),
RGS16 residues 58–177 (chain B); complex 2: Go residues
35–345 (chain C), RGS16 residues 64–176 (chain D); 2 GDP, 2
Mg2, 2 AlF4 and 6 water molecules. Data collection, phasing
information and refinement statistics are presented in Table S1.
Figures were generated by using PyMol (DeLano Scientific).
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Fig. S1. Sequence alignment of RGS domains highlighting RGS16-Go binding determinants. Alignment was performed in CLUSTALW and modified manually
(7). Secondary structure and amino acid numbering for mouse RGS16 is indicated above the alignment. Eighty-eight percent identity and 88% similarity are
highlighted in green and yellow respectively. The divergent residue Thr-158 is highlighted in red. Amino acids that form contacts with Go are indicated above
the alignment and highlighted magenta. Sequences from top to bottom correspond with GenBank accession nos. NP056626.1, O14921, P49799, NP033089.2,
AAF34625.1, P49796, P49804, P97428, AAC69175.1, O46469, AAD34717.1, O54829, P49809, NP004697.2, NP003493, O14924, and P97492, respectively.
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Fig. S2. Sequence alignment of heterotrimeric G subunits. Alignment performed by using CLUSTALW and modified manually (7). Protein sequences (from
top to bottom) are from GenBank or the PDB with accession nos. NP034438, P10824, NP037238, NP112297, CAA26285, 2BCJQ, 1ZCAB, 1ZCBA, and P04896,
respectively. Secondary structure and amino acid numbering for Go is indicated above the alignment and color coded as in A. Eighty-nine percent identity and
89% similarity are highlighted in green and yellow, respectively. Residues identical across Gi1–3 and Gt but not identical in Go are highlighted in red. Residues
identical across Gi1–3 but not identical in Go are highlighted in blue. Amino acids that form contacts with RGS16 are indicated above the alignment and
highlighted magenta.
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Table S1. Crystallographic data collection and refinement statistics
Crystallographic/model parameter
Crystal structures
GoGDPAlF4RGS16 RGS16
X-ray diffraction data
Space group P3221 P212121
Unit cell dimensions, a, b, c; Å 96.4, 96.4, 235.6 47.4, 71.7, 72.3
Resolution, Å 50–2.9 50–1.89
Reflections, total 27,489 20,395
Redundancy 7.5 (3.0) 2.5 (1.9)
Completeness, % 83.0 (48.2) 94.6 (75.7)
Rsym, % 7.8 (36.3) 4.3 (11.0)
I/ 20.2 (2.0) 21.3 (5.2)
Molecular replacement
Search model (PDB code) Gi1GDPAlF4 RGS4 (1AGR) RGS4 (1AGR)
Rotation 1, 1, 2, 3; deg. 201.0, 49.4, 190.7 359.2, 24.0, 180.1
Translation 1 x, y, z; Å 36.0, 71.3, 16.0 3.14, 19.0, 29.85
 above mean monitor value 2.3 2.5
Rotation 2, 1, 2, 3; deg. 208.5, 43.3, 186.1 355.7, 25.1, 180.5
Translation 2, x, y, z; Å 54.8, 73.0, 99.8 21.7, 15.1, 31.2
 above mean monitor value 3.0 3.6
Refinement statistics
Reflections, total no. 24,012 19,238
Reflections, working set 21,645 17,342
Reflections, test set 2365 1896
Rwork, % 25.1 22.2
Rfree, % 30.5 26.8
Non-hydrogen atoms 6,889 2,235
Waters 6 179
Average B-factor, Å2 (min/max) 93.1 (19.0/180.0) 14.3 (1.6/41.9)
rmsd bond length, Å 0.009 0.005
rmsd bond angles, deg. 1.4 1.0
rmsd dihedral angles, deg. 20.5 18.0
rmsd improper angles, deg. 0.8 0.8
Numbers in parentheses refer to the highest resolution shell in the structural refinement unless otherwise noted.RsymhkljIj(hkl) I(hkl) /Ij(hkl).Rwork
hklFo(hkl)  Fc(hkl)/hklFo(hkl). Rfree  hklFo(hkl)  Fc(hkl)/hklFo(hkl), calculated from reflections (10% of total) delineated as a test set of randomly
selected data.
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